{"disease":{"id":"cystic-kidney-disease","name":"cystic kidney disease"},"drugs":{"marketed":[{"drug_id":"tolvaptan","indication_name":"Polycystic kidney disease, adult type","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Samsca","generic_name":"TOLVAPTAN","company_name":"Otsuka","drug_phase":"marketed","molecular_target":"Vasopressin V2 receptor","drug_class":"Vasopressin V2 Receptor Antagonist [EPC]","quality_score":80,"revenue":"1200","mechanism":"Samsca works by blocking the action of vasopressin, a hormone that regulates water levels in the body."}],"pipeline":[],"offLabel":[],"totalMarketed":1,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06065852","title":"National Registry of Rare Kidney Diseases","phase":"","overall_status":"RECRUITING","enrollment_count":35000,"lead_sponsor_name":"UK Kidney Association","has_results":false},{"nct_id":"NCT04039061","title":"ADPKD Patient Registry","phase":"","overall_status":"RECRUITING","enrollment_count":3000,"lead_sponsor_name":"PKD Foundation","has_results":false},{"nct_id":"NCT02112136","title":"Clinical and Molecular Description of PKD1 and PKD2 Mutation Negative Carriers in ADPKD","phase":"NA","overall_status":"COMPLETED","enrollment_count":1450,"lead_sponsor_name":"University Hospital, Brest","has_results":false},{"nct_id":"NCT01214421","title":"Tolvaptan Extension Study in Participants With ADPKD","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1083,"lead_sponsor_name":"Otsuka Pharmaceutical Development & Commercialization, Inc.","has_results":true},{"nct_id":"NCT05215964","title":"The Association Between Skeletal Muscle Mass and Severity of Polycystic Liver Disease and Polycystic Kidney Disease","phase":"","overall_status":"UNKNOWN","enrollment_count":600,"lead_sponsor_name":"National Taiwan University Hospital","has_results":false},{"nct_id":"NCT06036992","title":"Study and Management of Cystic Complications in Autosomal Dominant Polycystic Kidney Disease","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":600,"lead_sponsor_name":"University Hospital, Brest","has_results":false},{"nct_id":"NCT02925221","title":"Canadian Medical Assessment of JINARC™ Outcomes Registry","phase":"","overall_status":"COMPLETED","enrollment_count":530,"lead_sponsor_name":"Otsuka Canada Pharmaceutical Inc.","has_results":false},{"nct_id":"NCT02948179","title":"Using Preimplantation Genetic Diagnosis in Autosomal Dominant Polycystic Kidney Disease Patients: a Multicenter Clinical Trial","phase":"NA","overall_status":"COMPLETED","enrollment_count":459,"lead_sponsor_name":"Changlin Mei","has_results":false},{"nct_id":"NCT06747572","title":"Polycystic Kidney Disease 1 (PKD1) Gene Variant Groups in Autosomal Dominant Polycystic Kidney Disease","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":401,"lead_sponsor_name":"Vertex Pharmaceuticals Incorporated","has_results":false},{"nct_id":"NCT06618638","title":"Shared Decision Making for Choosing Autosomal DOminant Polycystic Kidney Disease Treatment","phase":"NA","overall_status":"RECRUITING","enrollment_count":340,"lead_sponsor_name":"Seoul National University Hospital","has_results":false},{"nct_id":"NCT03970018","title":"ADPKD and Peritoneal Dialysis: How Anticipate Peritoneal Pressure?","phase":"","overall_status":"COMPLETED","enrollment_count":210,"lead_sponsor_name":"CHU de Reims","has_results":false},{"nct_id":"NCT05286632","title":"KidneYou - Innovative Digital Therapy","phase":"NA","overall_status":"COMPLETED","enrollment_count":210,"lead_sponsor_name":"Advice Pharma Group srl","has_results":false},{"nct_id":"NCT02127437","title":"Lanreotide In Polycystic Kidney Disease Study","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":159,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT06345755","title":"A Phase 1 Study to Evaluate Safety, Tolerability, and Pharmacokinetics of VX-407 in Healthy Participants","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":159,"lead_sponsor_name":"Vertex Pharmaceuticals Incorporated","has_results":false},{"nct_id":"NCT03889392","title":"Evaluation of Nephrectomy Specimen for Intracranial Aneurysm Development in ADPKD","phase":"","overall_status":"COMPLETED","enrollment_count":154,"lead_sponsor_name":"Asan Medical Center","has_results":false},{"nct_id":"NCT04689074","title":"Establishment of the Human Intestinal and Salivary Microbiota Biobank - Kidney Diseases","phase":"","overall_status":"COMPLETED","enrollment_count":150,"lead_sponsor_name":"Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari","has_results":false},{"nct_id":"NCT06800651","title":"Trial of JMKX003142 in Participants With Rapidly Progressive Autosomal Dominant Polycystic Kidney Disease (ADPKD)","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":135,"lead_sponsor_name":"Jemincare","has_results":false},{"nct_id":"NCT07282821","title":"Bempedoic Acid Therapy for Polycystic Kidney Disease","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":120,"lead_sponsor_name":"Kenneth Hallows","has_results":false},{"nct_id":"NCT03949894","title":"Evaluating the Safety and effectivenesS in Adult KorEaN Patients Treated With Tolvaptan for Management of Autosomal domInAnt poLycystic Kidney Disease","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":118,"lead_sponsor_name":"Korea Otsuka Pharmaceutical Co., Ltd.","has_results":false},{"nct_id":"NCT02729662","title":"Efficacy of Tolvaptan on ADPKD Patients","phase":"NA","overall_status":"UNKNOWN","enrollment_count":118,"lead_sponsor_name":"Kyorin University","has_results":false},{"nct_id":"NCT07565441","title":"Drug-Drug Interactions of JMKX003142 in Healthy Participants","phase":"PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":112,"lead_sponsor_name":"Jemincare","has_results":false},{"nct_id":"NCT03901521","title":"Autosomal Dominant Polycystic Kidney Disease Somatic Mutation Biorepository","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":100,"lead_sponsor_name":"Weill Medical College of Cornell University","has_results":false},{"nct_id":"NCT07083557","title":"Routine Validation and Reproducibility Testing of Laboratory Assays and Research Techniques Used for Endocrine, Cardiometabolic, and Musculoskeletal Disorder Research (VALD)","phase":"","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"Bettina Mittendorfer","has_results":false},{"nct_id":"NCT07217158","title":"Role of ROS and cAMP-PKA Biomarkers in ADPKD","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":100,"lead_sponsor_name":"Mayo Clinic","has_results":false},{"nct_id":"NCT02964273","title":"Safety, Pharmacokinetics, Tolerability and Efficacy of Tolvaptan in Children and Adolescents With ADPKD (Autosomal Dominant Polycystic Kidney Disease)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":91,"lead_sponsor_name":"Otsuka Pharmaceutical Development & Commercialization, Inc.","has_results":true},{"nct_id":"NCT07074327","title":"Effects of VX-407 on the Pharmacokinetics of Oral Contraceptives in Healthy Participants","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":74,"lead_sponsor_name":"Vertex Pharmaceuticals Incorporated","has_results":false},{"nct_id":"NCT05500157","title":"Assessment of Treatment With Laparoscopic Fenestration or Aspiration Sclerotherapy for Large Symptomatic Hepatic Cysts","phase":"NA","overall_status":"UNKNOWN","enrollment_count":70,"lead_sponsor_name":"Radboud University Medical Center","has_results":false},{"nct_id":"NCT05521191","title":"A Study of RGLS8429 in Patients With Autosomal Dominant Polycystic Kidney Disease","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":68,"lead_sponsor_name":"Regulus Therapeutics Inc.","has_results":false},{"nct_id":"NCT04578548","title":"A Study to Evaluate the Effects of GLPG2737 in Participants With Autosomal Dominant Polycystic Kidney Disease (ADPKD)","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":66,"lead_sponsor_name":"Galapagos NV","has_results":true},{"nct_id":"NCT07201025","title":"Imaging Assessments of ARPKD Kidney Disease Progression","phase":"","overall_status":"RECRUITING","enrollment_count":60,"lead_sponsor_name":"The Cleveland Clinic","has_results":false},{"nct_id":"NCT07355114","title":"Robotic vs Open Nephrectomy for ADPKD","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":57,"lead_sponsor_name":"University of Bologna","has_results":false},{"nct_id":"NCT04363554","title":"The Kidneys Ability to Concentrate and Dilute Urine in Patients With Autosomal Dominant Polycystic Kidney Disease","phase":"NA","overall_status":"COMPLETED","enrollment_count":51,"lead_sponsor_name":"Regional Hospital Holstebro","has_results":false},{"nct_id":"NCT07181265","title":"Drug-Drug Interaction of JMKX003142 With Amiodarone and Febuxostat in Healthy Subjects","phase":"PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":48,"lead_sponsor_name":"Jemincare","has_results":false},{"nct_id":"NCT06658964","title":"Study to Evaluate the Drug-drug Interaction of JMKX003142 in Healthy Subjects","phase":"PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":48,"lead_sponsor_name":"Jemincare","has_results":false},{"nct_id":"NCT07310641","title":"Descriptive Analysis of Preimplantation Genetic Test (PGT)in Couples With Polycystic Kidney Disease (PKD). In the ADPKD Subgroup Evaluation of Outcomes and Complications Comparing Couples in Which the Father is Affected With Couples in Which the Mother is Affected","phase":"","overall_status":"COMPLETED","enrollment_count":44,"lead_sponsor_name":"Azienda Sanitaria Universitaria Integrata del Trentino","has_results":false},{"nct_id":"NCT02933268","title":"High Water Intake in Polycystic Kidney Disease","phase":"NA","overall_status":"COMPLETED","enrollment_count":42,"lead_sponsor_name":"Cambridge University Hospitals NHS Foundation Trust","has_results":false},{"nct_id":"NCT07228364","title":"Safety, Tolerability and Pharmacokinetics of AZD1613 in Adults With Autosomal Dominant Polycystic Kidney Disease","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":40,"lead_sponsor_name":"AstraZeneca","has_results":false},{"nct_id":"NCT02558595","title":"Pilot Study of Niacinamide in Polycystic Kidney Disease (NIAC-PKD2)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":36,"lead_sponsor_name":"University of Kansas Medical Center","has_results":false},{"nct_id":"NCT05190744","title":"Probenecid (PB) to Treat Hereditary Nephrogenic Diabetes Insipidus (NDI), ADPKD Treated With Tolvaptan, and Severely Polyuric Patients With Previous Lithium Administration","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":36,"lead_sponsor_name":"Mayo Clinic","has_results":false},{"nct_id":"NCT06728228","title":"Amnioinfusion for Fetal Renal Failure","phase":"NA","overall_status":"RECRUITING","enrollment_count":35,"lead_sponsor_name":"Fetal Care Center, PLLC","has_results":false},{"nct_id":"NCT07022119","title":"A Phase 1 Study Evaluating Safety, Tolerability, and Pharmacokinetics of VX-407 in Healthy Participants","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":32,"lead_sponsor_name":"Vertex Pharmaceuticals Incorporated","has_results":false},{"nct_id":"NCT03487913","title":"The ELiSA Study - Evaluation of Lixivaptan in Subjects With Autosomal Dominant Polycystic Kidney Disease","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":31,"lead_sponsor_name":"Palladio Biosciences","has_results":true},{"nct_id":"NCT06601829","title":"Congenital Hepatic Fibrosis and Autosomal Recessive Polycystic Kidney Disease in Children at Sohag University Hospital","phase":"","overall_status":"RECRUITING","enrollment_count":30,"lead_sponsor_name":"Sohag University","has_results":false},{"nct_id":"NCT06841224","title":"The Factors Affecting IPP in Peritoneal Dialysis Patients with Polycystic Kidney Disease","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":30,"lead_sponsor_name":"Peking University First Hospital","has_results":false},{"nct_id":"NCT07535385","title":"RADIOLOGICAL AND CLINICAL EVALUATION OF RENAL EMBOLIZATION USING EVOH IN DIALYSIS PATIENTS WITH AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE: A PROSPECTIVE LONGITUDINAL OBSERVATIONAL STUDY","phase":"","overall_status":"RECRUITING","enrollment_count":30,"lead_sponsor_name":"Fondazione IRCCS Policlinico San Matteo di Pavia","has_results":false},{"nct_id":"NCT03442647","title":"Dynamic Measurement of Renal Functional Reserve as a Predictor of Long-Term Renal Function","phase":"NA","overall_status":"UNKNOWN","enrollment_count":30,"lead_sponsor_name":"Thomas Mueller","has_results":false},{"nct_id":"NCT03196076","title":"Contrast-enhanced Ultrasound for Complex Kidney Lesion Diagnosis in Patients With CKD Extension","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":25,"lead_sponsor_name":"University of North Carolina, Chapel Hill","has_results":true},{"nct_id":"NCT04705051","title":"Long-term Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD) With Venglustat","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":24,"lead_sponsor_name":"Sanofi","has_results":true},{"nct_id":"NCT07161037","title":"Phase 2a Study of VX-407 in Participants With ADPKD Who Have a Subset of PKD1 Gene Variants (AGLOW)","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":24,"lead_sponsor_name":"Vertex Pharmaceuticals Incorporated","has_results":false},{"nct_id":"NCT07470177","title":"A Study to Investigate the Effects of JMKX003142 on QTc Interval in Healthy Adults","phase":"PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":24,"lead_sponsor_name":"Jemincare","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}